Summary GeneFirst Ltd (GeneFirst) is a molecular diagnostics company that develops technologies and products in the fields of infectious disease, cancer diagnostics and personalized medicine. The company's research products include MMD-PCR mutation detection kits, PCDR master mix, MPA-HPV test and PCDR-Dengue virus test. It offers multiplex mutation detection PCR Test Kit that include, GeneFirst Epidermal Growth Factor Receptor (EGFR), Kirsten rat sarcoma viral oncogene (KRAS), v-Raf murine sarcoma viral oncogene homolog B1 (BRAF), Janus kinase 2 (JAK2), phosphatidylinositol 3-kinase catalytic subunit (PIK3CA) and Abelson murine leukaemia viral oncogene homolog 1 (ABL). GeneFirst offers customised SNP genotyping, pathogen and mutation detection services. The company offers its products to researchers, clinicians and drug companies. GeneFirst is headquartered in Abingdon, the UK. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company GeneFirst Ltd - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 GeneFirst Ltd Company Snapshot 5 GeneFirst Ltd Company Overview 5 GeneFirst Ltd Pipeline Products and Clinical Trials Overview 5 GeneFirst Ltd - Pipeline Analysis Overview 7 Key Facts 7 GeneFirst Ltd - Major Products and Services 8 GeneFirst Ltd Pipeline Products by Development Stage 9 GeneFirst Ltd Pipeline Products Overview 11 GFscreen BRAF Mutation Detection Kit 11 GFscreen BRAF Mutation Detection Kit Product Overview 11 GFscreen EGFR Mutation Detection Kit 12 GFscreen EGFR Mutation Detection Kit Product Overview 12 GFscreen KRAS Mutation Detection Kit 13 GFscreen KRAS Mutation Detection Kit Product Overview 13 PCDR - Dengue Test 14 PCDR - Dengue Test Product Overview 14 GeneFirst Ltd - Key Competitors 15 GeneFirst Ltd - Key Employees 16 GeneFirst Ltd - Locations And Subsidiaries 17 Head Office 17 Appendix 18 Methodology 18 About GlobalData 18 Contact Us 18 Disclaimer 18
List of Tables
GeneFirst Ltd Pipeline Products and Clinical Trials Overview 5 GeneFirst Ltd Pipeline Products by Equipment Type 6 GeneFirst Ltd Pipeline Products by Indication 6 GeneFirst Ltd, Key Facts 7 GeneFirst Ltd, Major Products and Services 8 GeneFirst Ltd Number of Pipeline Products by Development Stage 9 GeneFirst Ltd Pipeline Products Summary by Development Stage 10 GFscreen BRAF Mutation Detection Kit - Product Status 11 GFscreen BRAF Mutation Detection Kit - Product Description 11 GFscreen EGFR Mutation Detection Kit - Product Status 12 GFscreen EGFR Mutation Detection Kit - Product Description 12 GFscreen KRAS Mutation Detection Kit - Product Status 13 GFscreen KRAS Mutation Detection Kit - Product Description 13 PCDR - Dengue Test - Product Status 14 PCDR - Dengue Test - Product Description 14 GeneFirst Ltd, Key Employees 16
List of Figures
GeneFirst Ltd Pipeline Products by Equipment Type 6 GeneFirst Ltd Pipeline Products by Development Stage 9
Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certainRead More...
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous industRead More...
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.